Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinping Zheng

Showing results (121-130 of 170) with videos related to

Pageof 17
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|April 14, 2017
Mucoactive and antioxidant medicines for COPD: consensus of a group of Chinese pulmonary physiciansXixin Yan, Yuanlin Song, Ce Shen, et al.
Current Medical Research and Opinion|October 30, 2020
Single inhaler triple therapy (FF/UMEC/VI) versus FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the China cohort in the IMPACT trialJinping Zheng, Nanshan Zhong, Changzheng Wang, et al.
Journal of Thoracic Disease|July 10, 2020
Sputum and serum autoantibody profiles and their clinical correlation patterns in COPD patients with and without eosinophilic airway inflammationZhenyu Liang, Fengyan Wang, Dongying Zhang, et al.
COPD|September 29, 2018
The Efficacy and Safety of Once-daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-daily Budesonide/Formoterol in a Subgroup of Patients from China with Symptomatic COPD at Risk of Exacerbations (FULFIL Trial)Jinping Zheng, Nanshan Zhong, Changzheng Wang, et al.
BMC Infectious Diseases|January 3, 2024
Hospitalization, case fatality, comorbidities, and isolated pathogens of adult inpatients with pneumonia from 2013 to 2022: a real-world study in Guangzhou, ChinaYun Li, Zhufeng Wang, Lunfang Tan, et al.
Journal of Thoracic Disease|December 23, 2017
Reference values for spirometry in Chinese aged 4-80 yearsWenhua Jian, Yi Gao, Chuangli Hao, et al.
BMC Pulmonary Medicine|May 10, 2025
The Reliability of a Novel Structured Testing Device for Single-breath Lung Carbon Monoxide Uptake: A Randomized Comparison Crossover StudyShihua Yao, Tuping Fu, Kuiqing Lin, et al.
Asia Pacific Family Medicine|May 5, 2015
Impact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: the EPIC Asia population-based surveySam Lim, David Chi-Leung Lam, Abdul Razak Muttalif, et al.
Chest|October 19, 2013
Roflumilast for the treatment of COPD in an Asian population: a randomized, double-blind, parallel-group studyJinping Zheng, Jinghua Yang, Xiangdong Zhou, et al.
The Lancet. Respiratory Medicine|October 4, 2020
Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 studyPaul M O'Byrne, J Mark FitzGerald, Eric D Bateman, et al.
Pageof 17

Showing results (121-130 of 170) with videos related to

Sort By:
Pageof 17
International Journal of Chronic Obstructive Pulmonary Disease|April 14, 2017
Mucoactive and antioxidant medicines for COPD: consensus of a group of Chinese pulmonary physiciansXixin Yan, Yuanlin Song, Ce Shen, et al.
Current Medical Research and Opinion|October 30, 2020
Single inhaler triple therapy (FF/UMEC/VI) versus FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the China cohort in the IMPACT trialJinping Zheng, Nanshan Zhong, Changzheng Wang, et al.
Journal of Thoracic Disease|July 10, 2020
Sputum and serum autoantibody profiles and their clinical correlation patterns in COPD patients with and without eosinophilic airway inflammationZhenyu Liang, Fengyan Wang, Dongying Zhang, et al.
COPD|September 29, 2018
The Efficacy and Safety of Once-daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-daily Budesonide/Formoterol in a Subgroup of Patients from China with Symptomatic COPD at Risk of Exacerbations (FULFIL Trial)Jinping Zheng, Nanshan Zhong, Changzheng Wang, et al.
BMC Infectious Diseases|January 3, 2024
Hospitalization, case fatality, comorbidities, and isolated pathogens of adult inpatients with pneumonia from 2013 to 2022: a real-world study in Guangzhou, ChinaYun Li, Zhufeng Wang, Lunfang Tan, et al.
Journal of Thoracic Disease|December 23, 2017
Reference values for spirometry in Chinese aged 4-80 yearsWenhua Jian, Yi Gao, Chuangli Hao, et al.
BMC Pulmonary Medicine|May 10, 2025
The Reliability of a Novel Structured Testing Device for Single-breath Lung Carbon Monoxide Uptake: A Randomized Comparison Crossover StudyShihua Yao, Tuping Fu, Kuiqing Lin, et al.
Asia Pacific Family Medicine|May 5, 2015
Impact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: the EPIC Asia population-based surveySam Lim, David Chi-Leung Lam, Abdul Razak Muttalif, et al.
Chest|October 19, 2013
Roflumilast for the treatment of COPD in an Asian population: a randomized, double-blind, parallel-group studyJinping Zheng, Jinghua Yang, Xiangdong Zhou, et al.
The Lancet. Respiratory Medicine|October 4, 2020
Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 studyPaul M O'Byrne, J Mark FitzGerald, Eric D Bateman, et al.
Pageof 17